Methyl Salicylate


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1385 CREB1 Affects expression PMID:20385217
140809 SRXN1 Increases expression PMID:20566472
1645 AKR1C1 Increases expression PMID:20566472
171284 TIMD2 Affects expression PMID:22302311
17231 MCPT8 Affects expression PMID:22302311
1728 NQO1 Increases expression PMID:20566472
2010 EMD Affects expression PMID:19527780
2099 ESR1 Affects expression PMID:19527780
2235 FECH Increases expression PMID:20566472
22949 PTGR1 Increases expression PMID:20566472
231 AKR1B1 Increases expression PMID:20566472
2512 FTL Increases expression PMID:20566472
2539 G6PD Increases expression PMID:20566472
2729 GCLC Increases expression PMID:20566472
2730 GCLM Increases expression PMID:20566472
2920 CXCL2 Affects expression PMID:23178550
2936 GSR Increases expression PMID:20566472
3162 HMOX1 Increases expression PMID:20566472
3283 HSD3B1 Decreases activity PMID:39159849
3552 IL1A Increases expression PMID:23178550
3565 IL4 Affects expression PMID:22302311
3576 CXCL8 Increases expression PMID:27965148; PMID:31734321; PMID:31734321
3605 IL17A Decreases expression PMID:28826779
3685 ITGAV Affects expression PMID:22302311
3963 LGALS7 Affects expression PMID:22302311
4097 MAFG Increases expression PMID:20566472
4199 ME1 Increases expression PMID:20566472
4288 MKI67 Affects expression PMID:22302311
4790 NFKB1 Decreases expression PMID:20385217
4883 NPR3 Affects expression PMID:19527780
5226 PGD Increases expression PMID:20566472
57016 AKR1B10 Increases expression PMID:20566472
7060 THBS4 Affects expression PMID:22302311
7124 TNF Affects expression PMID:20385217
7296 TXNRD1 Increases expression PMID:20566472
730249 ACOD1 Affects expression PMID:22302311
8644 AKR1C3 Increases expression PMID:20566472
891 CCNB1 Affects expression PMID:22302311
922 CD5L Affects expression PMID:22302311
9514 GAL3ST1 Affects expression PMID:19527780
983 CDK1 Affects expression PMID:22302311

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.